WVE

2.5605.88%
GL

Gregory L. Verdine

Founder & Director

Dr. Gregory L. Verdine (Greg), Ph.D., serves as Venture Partner at Andreessen Horowitz LLC since July 2023. He joined the firm in July 2023 and focuses on Bio + Health as part of the Bio + Health Special Advisors Team. Dr. Verdine is Founder and Director of Wave Life Sciences, Inc. since July 2013 and previously served as its Chairman from July 2013 to September 2017. He is Co-Founder, President, Chief Executive Officer and Director of LifeMine Therapeutics Inc. and previously served as its Chief Scientific Officer and Executive Director. He is also Co-Founder, Chairman of the Scientific Advisory Board and Director of Warp Drive Bio LLC since July 2013. Dr. Verdine serves as Chairman of the Scientific Advisory Board of ShangPharma Corporation and as Member of Science & Medical Advisory at N-of-One Inc. He is also Venture Partner at 6 Dimensions Capital Limited. Earlier in his career, Dr. Verdine served as Director of Enanta Pharmaceuticals Inc. from 1996 to August 18, 2013 and as Scientific Advisor at Vertex Pharmaceuticals Incorporated. He also served as Venture Partner at Third Rock Ventures LLC and Apple Tree Partners. Dr. Verdine was Co-Founder of Sesen Bio Inc. and Founder of Tokai Pharmaceuticals Inc. He also served as Advisor at Variagenics Inc. and held scientific advisory roles at Amphora Discovery Corporation, FORUM Pharmaceuticals Inc. and Spinal Muscular Atrophy Foundation. He was also Co-Founder and Chairman of the Scientific Advisory Board of Gloucester Pharmaceuticals Inc. since 2003 and served as Chairman of the Scientific Advisory Board of Rein Therapeutics Inc. Additionally, Dr. Verdine was Co-Founder and Vice Chairman of Parabilis Medicines Inc. from June 2023 to 2025 and previously served as Chief Executive Officer, President, Treasurer, Secretary and Chairman of the Board from November 2022 to June 2023. In academia, Dr. Verdine served as Professor at Harvard University and Harvard Medical School, contributing to advancements in chemical biology and drug discovery. Dr. Verdine holds a B.S. in Chemistry from Saint Joseph's University, a Ph.D. in Organic Chemistry from Columbia University and a Ph.D. from Clarkson University.

Positions